Mandatory public reporting of healthcare-associated infections in developed countries: How can developing countries follow?

Journal of Hospital Infection

Volumn 90, Issue 1, 2015, Pages 12-14

  Biswal, M ^a   Mewara, A ^a   Appannanavar, S B ^a   Taneja, N ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Healthcare associated infections; India; Mandatory; Public reporting

Indexed keywords

ACCREDITATION; ACINETOBACTER INFECTION; BACTEREMIA; BLOODSTREAM INFECTION; CLOSTRIDIUM INFECTION; DEVELOPED COUNTRY; DEVELOPING COUNTRY; EMPOWERMENT; EPIDEMIC; ESCHERICHIA COLI INFECTION; FRANCE; FUNDING; GOVERNMENT REGULATION; GROSS NATIONAL PRODUCT; HAND WASHING; HEALTH CARE POLICY; HEALTH MAINTENANCE ORGANIZATION; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INDIA; INDICATOR ORGANISM; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFECTIOUS DIARRHEA; INTERPERSONAL COMMUNICATION; JAPAN; MANDATORY PROGRAM; MANDATORY REPORTING; MASS MEDIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS BACTEREMIA; NATIONAL HEALTH SERVICE; NONHUMAN; NOTE; PRIVATE HOSPITAL; QUALITY CONTROL; STAPHYLOCOCCUS INFECTION; UNITED KINGDOM; UNITED STATES; VENTILATOR ASSOCIATED PNEUMONIA; WASTE DISPOSAL; COMPLIANCE (PHYSICAL); CROSS INFECTION; ETHICS; HEALTH CARE PERSONNEL; HOSPITAL; LAW; LEGISLATION AND JURISPRUDENCE; STANDARDS;

BENCHMARKING; COMPLIANCE; CROSS INFECTION; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HEALTH PERSONNEL; HOSPITALS; HUMANS; INDIA; INFECTION CONTROL; LEGISLATION, HOSPITAL; MANDATORY REPORTING;

EID: 84926957055     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2014.12.011     Document Type: Note

References (22)

1. Johnson A.P., Davies J., Guy R., et al. Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. JAntimicrob Chemother 2012, 67:802-809.
2. Wilson A.P., Kiernan M. Recommendations for surveillance priorities for healthcare-associated infections and criteria for their conduct. JAntimicrob Chemother 2012, 67(Suppl. 1):i23-i28.
3. Underwood J., Klein J.L., Newsholme W. Escherichia coli bacteraemia: how preventable is it?. JHosp Infect 2011, 79:364-365.
4. Dumartin C., Rogues A.M., Amadeo B., et al. Antibiotic stewardship programmes: legal framework and structure and process indicator in Southwestern French hospitals, 2005-2008. JHosp Infect 2011, 77:123-128.
5. Jarvis W.R. The Lowbury Lecture. The United States approach to strategies in the battle against healthcare-associated infections, 2006: transitioning from benchmarking to zero tolerance and clinician accountability. JHosp Infect 2007, 65(Suppl. 2):3-9.
6. Wunderink R.G. Ventilator-associated tracheobronchitis: public-reporting scam or important clinical infection?. Chest 2011, 139:485-488.
7. Daneman N., Stukel T.A., Ma X., Vermeulen M., Guttmann A. Reduction in Clostridium difficile infection rates after mandatory hospital public reporting: findings from a longitudinal cohort study in Canada. PLoS Med 2011, 9:e1001268.
8. Pittet D., Allegranzi B., Storr J., et al. Infection control as a major World Health Organization priority for developing countries. JHosp Infect 2008, 68:285-292.
9. Ministry of Environment and Forests, Notification N. S.O.630 (E). Biomedical waste (management and handling) rules, 1998. The Gazette of India, Extraordinary, Part II, Section 3(ii), 27th July 1998.
10. Cooke E.M., Coello R., Sedgwick J., et al. Anational surveillance scheme for hospital associated infections in England. Team of the Nosocomial Infection National Surveillance Scheme. JHosp Infect 2000, 46:1-3.
11. Arias K.M. Mandatory reporting and pay for performance: health care infections in the limelight. AORN J 2008, 87:750-758.
12. Tokars J.I., Richards C., Andrus M., et al. The changing face of surveillance for health care-associated infections. Clin Infect Dis 2004, 39:1347-1352.
13. Lilford R.J., Brown C.A., Nicholl J. Use of process measures to monitor the quality of clinical practice. BMJ 2007, 335:648-650.
14. Pittet D., Zingg W. Reducing ventilator-associated pneumonia: when process control allows outcome improvement and even benchmarking. Crit Care Med 2010, 38:983-984.
15. Oh J.Y., Cunningham M.C., Beldavs Z.G., et al. Statewide validation of hospital-reported central line-associated bloodstream infections: Oregon, 2009. Infect Control Hosp Epidemiol 2012, 33:439-445.
16. Martin M., Zingg W., Hansen S., et al. Public reporting of healthcare-associated infection data in Europe. What are the views of infection prevention opinion leaders?. JHosp Infect 2013, 83:94-98.
17. Pearson A., Chronias A., Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. JAntimicrob Chemother 2009, 64(Suppl. 1):i11-i17.
18. Yuji K., Oiso G., Matsumura T., Murashige N., Kami M. Police investigation into multidrug-resistant Acinetobacter baumannii outbreak in Japan. Clin Infect Dis 2011, 52:422.
19. Fung C.H., Lim Y.W., Mattke S., Damberg C., Shekelle P.G. Systematic review: the evidence that publishing patient care performance data improves quality of care. Ann Intern Med 2008, 148:111-123.
20. Uckay I., Ahmed Q.A., Sax H., Pittet D. Ventilator-associated pneumonia as a quality indicator for patient safety?. Clin Infect Dis 2008, 46:557-563.
21. Haustein T., Gastmeier P., Holmes A., et al. Use of benchmarking and public reporting for infection control in four high-income countries. Lancet Infect Dis 2011, 11:471-481.
22. Gravelle H., Sivey P. Imperfect information in a quality-competitive hospital market. JHealth Econ 2010, 29:524-535.